AN EFFICACY AND SAFETY STUDY OF AUTOLOGOUS CLUSTER OF DIFFERENTIATION 34 (CD34+) HEMATOPOIETIC PROGENITOR CELLS TRANSDUCED WITH PLACEBO OR AN ANTI- HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) RIBOZYME (OZ1) IN PARTICIPANTS WITH HIV-1 INFECTION: